The Valley Desk

NCT05096481 · Interventional trial

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Overall registry status Recruiting

Phase 2

Conditions Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Recurrent Medulloblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov